Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation (Q38889412)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation |
scientific article |
Statements
1 reference
Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation (English)
1 reference
Robert J Lutz
1 reference
E Erica Hong
1 reference
Hans Erickson
1 reference
Kathleen R Whiteman
1 reference
Gregory Jones
1 reference
Yelena Kovtun
1 reference
Veronique Blanc
1 reference
John M Lambert
1 reference
27 April 2015
1 reference
1 reference
12
1 reference
6
1 reference
1703-1716
1 reference
Identifiers
1 reference
1 reference